Kontour Medical Valuation
| 688314 Stock | 28.89 0.89 3.18% |
At this time, the firm appears to be overvalued. Kontour Medical Tech secures a last-minute Real Value of USD23.28 per share. The latest price of the firm is USD28.89. Our model forecasts the value of Kontour Medical Tech from analyzing the firm fundamentals such as EBITDA of 106.76 M, current valuation of 2.01 B, and Price To Sales of 7.61 X as well as examining its technical indicators and probability of bankruptcy.
Price Book 3.6764 | Enterprise Value 2 B | Enterprise Value Ebitda 18.3726 | Price Sales 7.6137 | Enterprise Value Revenue 6.5035 |
Overvalued
Today
Please note that Kontour Medical's price fluctuation is not too volatile at this time. Calculation of the real value of Kontour Medical Tech is based on 3 months time horizon. Increasing Kontour Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Kontour Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kontour Stock. However, Kontour Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 28.89 | Real 23.28 | Hype 29.71 |
The real value of Kontour Stock, also known as its intrinsic value, is the underlying worth of Kontour Medical Tech Company, which is reflected in its stock price. It is based on Kontour Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Kontour Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Kontour Medical Technology helps investors to forecast how Kontour stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kontour Medical more accurately as focusing exclusively on Kontour Medical's fundamentals will not take into account other important factors: Kontour Medical Cash |
|
Kontour Medical Total Value Analysis
Kontour Medical Technology is presently forecasted to have takeover price of 2.01 B with market capitalization of 2.01 B, debt of 37.97 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Kontour Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.01 B | 2.01 B | 37.97 M |
Kontour Medical Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Kontour suggests not a very effective usage of assets in November.Kontour Medical Profitability Analysis
The company reported the revenue of 275.03 M. Net Income was 75.51 M with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Kontour Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Kontour Medical and how it compares across the competition.
About Kontour Medical Valuation
The stock valuation mechanism determines Kontour Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Kontour Medical. We calculate exposure to Kontour Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Kontour Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 223.3 M | 186.6 M |
Kontour Medical Quarterly Retained Earnings |
|
Complementary Tools for Kontour Stock analysis
When running Kontour Medical's price analysis, check to measure Kontour Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kontour Medical is operating at the current time. Most of Kontour Medical's value examination focuses on studying past and present price action to predict the probability of Kontour Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kontour Medical's price. Additionally, you may evaluate how the addition of Kontour Medical to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |